The accumulation of the cellular labile iron pool (LIP) resulting from the inhibition of divalent metal transporter 1 (DMT1) can trigger ferroptosis, leading to the elimination of breast cancer stem cells and the reversal of multidrug resistance [57]. Here, SLC11A2 is linked to breast carcinoma.